KR810000557B1 - Manufacturing Process of Chiochroman Derivatives - Google Patents
Manufacturing Process of Chiochroman Derivatives Download PDFInfo
- Publication number
- KR810000557B1 KR810000557B1 KR7701932A KR770001932A KR810000557B1 KR 810000557 B1 KR810000557 B1 KR 810000557B1 KR 7701932 A KR7701932 A KR 7701932A KR 770001932 A KR770001932 A KR 770001932A KR 810000557 B1 KR810000557 B1 KR 810000557B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- derivatives
- carbon atoms
- alkyl group
- chiochroman
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title description 3
- -1 2,3-dihydroxypropyl Chemical group 0.000 claims description 21
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 150000001414 amino alcohols Chemical class 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- BHRZNVHARXXAHW-UHFFFAOYSA-N sec-butylamine Chemical compound CCC(C)N BHRZNVHARXXAHW-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- SSZWWUDQMAHNAQ-UHFFFAOYSA-N 3-chloropropane-1,2-diol Chemical compound OCC(O)CCl SSZWWUDQMAHNAQ-UHFFFAOYSA-N 0.000 description 2
- WJCTYFIAHVFXGY-UHFFFAOYSA-N 8-methoxy-2,3-dihydrothiochromen-4-one Chemical compound O=C1CCSC2=C1C=CC=C2OC WJCTYFIAHVFXGY-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000005576 amination reaction Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- YTFYDODBVNHGSQ-UHFFFAOYSA-N 2-(3,4-dihydro-2h-thiochromen-2-yloxymethyl)oxirane Chemical compound C1CC2=CC=CC=C2SC1OCC1CO1 YTFYDODBVNHGSQ-UHFFFAOYSA-N 0.000 description 1
- DXSUORGKJZADET-UHFFFAOYSA-N 3,3-dimethylbutan-2-amine Chemical compound CC(N)C(C)(C)C DXSUORGKJZADET-UHFFFAOYSA-N 0.000 description 1
- LJHYYURORLFPOJ-UHFFFAOYSA-N 3,4-dihydro-2h-thiochromen-2-ol Chemical compound C1=CC=C2SC(O)CCC2=C1 LJHYYURORLFPOJ-UHFFFAOYSA-N 0.000 description 1
- RGGVNXXEMZOMQS-UHFFFAOYSA-N 3,4-dihydro-2h-thiochromen-8-ol Chemical compound C1CCSC2=C1C=CC=C2O RGGVNXXEMZOMQS-UHFFFAOYSA-N 0.000 description 1
- CZCBWCFCHLILAR-UHFFFAOYSA-N 3-(3,4-dihydro-2H-thiochromen-8-yloxy)propane-1,2-diol Chemical compound OC(COC=1C=CC=C2CCCSC12)CO CZCBWCFCHLILAR-UHFFFAOYSA-N 0.000 description 1
- WVYNIWHEHBSTSB-UHFFFAOYSA-N 3-methylhexan-2-amine Chemical compound CCCC(C)C(C)N WVYNIWHEHBSTSB-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- KKMWRTKEUCTMEL-UHFFFAOYSA-N COC=1C=CC=C2C=CCSC12 Chemical compound COC=1C=CC=C2C=CCSC12 KKMWRTKEUCTMEL-UHFFFAOYSA-N 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- LVZGQWKTUCVPBQ-UHFFFAOYSA-N acetic acid;trifluoroborane Chemical compound CC(O)=O.FB(F)F LVZGQWKTUCVPBQ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 229940113088 dimethylacetamide Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000000075 primary alcohol group Chemical group 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000003198 secondary alcohol group Chemical group 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음.No content.
Description
본 발명은 치오크로말 유도체류의 제조공정에 관한 것으로 구조식(Ⅰ)과 같은 치오크로만 유도체의 제조공정을 제공하고 있다.The present invention relates to a process for producing a cheochrome derivatives, and provides a process for preparing a cheochrome derivative, such as the formula (I).
여기에서 A는 수소원자나 할로겐원자이고, R1은 수소원자, 또는 탄소수가 1-5인 직쇄 혹은 측쇄 알킬기이며, R2는 탄소수가 1-7인 알킬기나 탄소수가 3-6인 시클로 알킬기이다.Wherein A is a hydrogen atom or a halogen atom, R 1 is a hydrogen atom or a straight or branched chain alkyl group having 1 to 5 carbon atoms, R 2 is an alkyl group having 1 to 7 carbon atoms or a cycloalkyl group having 3 to 6 carbon atoms .
영국특허 제1,308,191호에 보면 이러한 화합물들 가운데 몇 가지가 소개되어 있고 아울러 그 제조방법으로서 구조식(Ⅱ)과 같은 하이드록시치오크로만과 1-클로로-2,3-에폭시프로판을 반응 시키고 그 결과 구성되는 구조식(Ⅲ)과 같은 (2,3-에폭시프로폭시)-치오크로만(2,3-epoxypropoxy)-thiochroman)을 구조식(Ⅳ)과 같은 1차 아민과 축합시키는 것으로 이루어지는 공정을 다루고 있다.In British Patent No. 1,308,191, some of these compounds are introduced, and as a preparation method, 1-chloro-2,3-epoxypropane is reacted with a hydroxythiochrome such as formula (II). A process consisting of condensing (2,3-epoxypropoxy) -thiochroman), such as formula (III), with a primary amine, such as formula (IV), is addressed.
위에서 R2는 탄소수가 1-5인 알킬기이거나 탄소수가 3-6인 시클로 알킬기이다.R 2 is an alkyl group having 1-5 carbon atoms or a cycloalkyl group having 3-6 carbon atoms.
본 발명은 앞의 공정에서 사용되는 구조식(Ⅳ)과 같은 아민의 지나친 사용량을 줄일 수 있고, 상기 공정의 각 과정에서 소요되는 시간은 상당히 감축시킬 수 있으며, 앞의 공정이 여분의 분해과정을 필요로 하는 반면에 구조식(Ⅰ)과 같은 광학적으로 활성인 화합물들은 광학적인 활성을 가진 아미노 화합물들로부터 제조될 수 있다는 관점들에 근거를 두고 있다.The present invention can reduce the excessive amount of the amine, such as the formula (IV) used in the previous process, the time required in each process of the process can be significantly reduced, the previous process requires an extra decomposition process On the other hand, optically active compounds such as formula (I) are based on the viewpoint that they can be prepared from amino compounds with optical activity.
따라서 본 발명에서는 구조식(Ⅱ)와 같은 하이드록시치오크로만을 염기성 매체내에서 1-할로겐 2,3-디하이드록시 프로판과 반응 시켜 구조식(Ⅴ)와 같은 (2,3-디하이드록시프로필옥시)치오크로만을 생성시키고, 이 글리콜을 구조식(Ⅵ)와 같은 아미노포스포늄할리이드 존재하에서 구조식(Ⅳ)의 아민과 반응시켜 구조식(Ⅰ)과 같은 아미노알코로 선택적으로 전환시키는 공정을 제공하고 있다.Therefore, in the present invention, by reacting only hydroxychirochloro as the formula (II) with 1-halogen 2,3-dihydroxy propane in a basic medium, it is possible to react with (2,3-dihydroxypropyloxy) as in the formula (V). The process provides a process for the selective conversion of an aminoalcohol, such as Formula (I), to produce only a chemokine and to react the glycol with an amine of the formula (IV) in the presence of an aminophosphonium halide, such as formula (VI).
구조식(Ⅵ)에서 R1'와 R2'는 저급 알킬이거나 페닐기이고, X는 할고겐 원자로서 일반적으로 요오드 원자이다.In the formula (VI), R 1 ′ and R 2 ′ are lower alkyl or phenyl groups and X is a halogen atom, generally an iodine atom.
본 발명에 따른 공정의 또 다른 잇점은 구조식(Ⅳ)와 같은 아민의 제한된 사용으로 하여 제2급 알콜 기에는 영향이 미치지 않고 제1급 알콜기의 선택적인 아민화가 가능하다는 점이다.Another advantage of the process according to the invention is that the limited use of amines such as formula (IV) allows selective amination of the primary alcohol groups without affecting the secondary alcohol groups.
구조식(Ⅳ)와 같은 아미노는 알킬아민이거나 시클로알킬아민이다. 이들의 하이드로카빌 사슬은 저급 알킬기와 같은 하나 또는 그 이상의 치환체, 혹은 피롤리디닐이나 피리딘 고리와 같은 방향족 이형사이클구조를 포함하기도 한다.Amino, such as formula (IV), is alkylamine or cycloalkylamine. Their hydrocarbyl chains may include one or more substituents, such as lower alkyl groups, or aromatic heterocycles, such as pyrrolidinyl or pyridine rings.
광학적으로 활성인 형태로서 아민을 사용하면 광학적인 활성을 가진 형태의 구조식(Ⅰ)과 같은 화합물이 생성된다. 광학적으로 활성이 아민류로서는 제2급부틸아민, (N-에틸피롤리디닐-2-) 메틸아민, 2-메틸시클로프로클아민, 3,3-디메틸-2-아미노부탄과 2-아미노-3-메틸헥산등이 사용될 수 있다.Use of an amine as an optically active form yields a compound of formula (I) in an optically active form. Optically active amines include secondary butylamine, (N-ethylpyrrolidinyl-2-) methylamine, 2-methylcycloproclamine, 3,3-dimethyl-2-aminobutane and 2-amino-3 -Methyl hexane and the like can be used.
본 발명의 일반적인 성질에 따르면 :According to the general nature of the invention:
(1) 구조식(Ⅱ)의 하이드록시치오크로만과 1-할로-2,3-디하이드록시 프로판사이의 반응은 나트륨이나 칼륨수산화물, 소다미드(Sodamide)나 나트륨 하이드라이드 등의 알칼리금속 수산화물과 같은 강염기 존재하에서 수행된다.(1) The reaction between the hydroxythiochroman of formula (II) and 1-halo-2,3-dihydroxy propane is carried out with alkali metal hydroxides such as sodium or potassium hydroxide, sodamide or sodium hydride. In the presence of the same strong base.
(2) 반응은 디메틸 포름아미드, 디메틸 아세트아미드, 또는 디메틸설폭사이드와 같은 극성의 비양자성용매 존재하에서 수행된다.(2) The reaction is carried out in the presence of a polar aprotic solvent, such as dimethyl formamide, dimethyl acetamide, or dimethyl sulfoxide.
(3) 반응은 50-150℃, 일반적으로는 75-125℃사이의 온도에서 수행된다.(3) The reaction is carried out at a temperature between 50-150 ° C., generally 75-125 ° C.
(4) 포스포늄할리드는 N-메틸-N-페닐아미노-트리페닐포스 포늄할리드, 일반적으로는 N-메틸-N-페닐아미노-트리페닐포스 포늄요오드이다.(4) Phosphonium halide is N-methyl-N-phenylamino-triphenylphosphonium halide, generally N-methyl-N-phenylamino-triphenylphosphonium iodine.
(5) 축합은 불활성 용매, 대개는 강극성의 용매내에서 이루어진다. 적당한 용매에는 벤젠과 톨루엔같은 방향족 탄화수소, 디메틸포름아미드, 디메틸 설폭사이드와 헥사메틸포스포아미드와 같은 극성 용매들이 있다.(5) Condensation takes place in an inert solvent, usually a highly polar solvent. Suitable solvents include aromatic hydrocarbons such as benzene and toluene, polar solvents such as dimethylformamide, dimethyl sulfoxide and hexamethylphosphoamide.
구조식(Ⅰ)의 치오크로만 유도체는 무기나 유기산, 특히 의학적으로 허용되는 무기나 유기산을 가함으로서 염화될 수 있다.Chiochroman derivatives of formula (I) can be chlorided by adding inorganic or organic acids, in particular pharmaceutically acceptable inorganic or organic acids.
구조식(Ⅰ)의 치오크로만 유도체와 그들의 의학적으로 허용되는 염류는, 특히 심장혈관계에 대한 요긴한 약리학적 및 치료적인 특성을 갖고 있으며, 비독성의 불활성 약제 조성물들의 형태로 심장의 베타-아드레날린 수용체의 차단제로 사용될 수도 있다.Chiochroman derivatives of structural formula (I) and their medically acceptable salts, which have essential pharmacological and therapeutic properties, particularly for the cardiovascular system, are beta-adrenergic receptors of the heart in the form of nontoxic inert pharmaceutical compositions. Can also be used as a blocker of.
본 발명의 아민화 반응은 일반적으로 이용되는 것이다. 그것은 상응하는 아미노알파-하이드록시 유도체를 생성시키기 위하여 어떤 글리콜에 적용되기도 한다.The amination reaction of the present invention is generally used. It may also be applied to any glycol to produce the corresponding aminoalpha-hydroxy derivatives.
출발물질로 사용되는 구조식(Ⅱ)의 하이드록시 화합물은 영국특허 제1,308, 191호와 1,261,111호에 기술되어 있다.Hydroxy compounds of formula (II) used as starting materials are described in British Patent Nos. 1,308, 191 and 1,261,111.
포스포늄할리드는 공지의 공정(다니가와, 테트라헤드론 레터 "1975" 471-472)에 따라 얻어질 수 있다. 하기의 실시예들은 본 발명을 예증하고 있다. 온도는 섭씨 온도이다.Phosphonium halide can be obtained according to a known process (Tanigawa, Tetraheadon Letter # 1975: 471-472). The following examples illustrate the invention. The temperature is in degrees Celsius.
[실시예 1]Example 1
[dl 8-(3-3차부틸아미노-2-하이드록시프로폭시)-치오크로만][dl 8- (3-tert-butylamino-2-hydroxypropoxy) -thiochromen]
[단계 A][Step A]
삼목 플라스크에 나트륨 수산화물 4g과 20ml의 물을 넣고 용해 시킨 다음, 200ml 에탄올중의 8-하이드록시치오크로만 16.6g을 가한다.In a cedar flask, 4 g of sodium hydroxide and 20 ml of water are added and dissolved. Then, 16.6 g of 8-hydroxythiochrome in 200 ml ethanol is added thereto.
이를 저어주면서 50℃에서 15분간 가열해준 다음, 12.1g의 1-클로로-2,3-디하이드록시프로판을 방울로 첨가한다. 50℃에서 3시간동안 유지시키고 매시간 1-클로로-2,3-디하이드록시프로판을 가한다.Stir and heat at 50 ° C. for 15 minutes, then add 12.1 g of 1-chloro-2,3-dihydroxypropane in drops. Hold at 50 ° C. for 3 hours and add 1-chloro-2,3-dihydroxypropane every hour.
반응매체를 최종적으로 50℃로 시간동안 가열해 주고, 실온으로 냉각시킨 다음 증발 건조시킨다. 그잔류 물을 물로 잡아서 신속히 교반해준다. 불용성 물질은 여과하여 버리고 중성이 될 때까지 물로 세척한 뒤 건조시킨다. 잔류물의 무게는 16g이다(수율=68%). 이것은 본질적으로 115°-120℃에서 용해하는 5-(2,3-디하이드록시프로폭시)치오크로만을 구성한다. 이를 에틸 아세 테이프에서 재결정시킴으로써 순도를 더 높일 수 있다.The reaction medium is finally heated to 50 ° C. over time, cooled to room temperature and evaporated to dryness. Grab the residue with water and stir quickly. Insoluble materials are filtered off, washed with water until neutral and dried. The residue weighed 16 g (yield = 68%). It consists essentially of only 5- (2,3-dihydroxypropoxy) thiok which dissolves at 115 ° -120 ° C. The purity can be further increased by recrystallization from ethyl acetate tape.
순수한 화합물은 118-120℃에서 용해한다.Pure compounds dissolve at 118-120 ° C.
[단계 B][Step B]
2.4g의 8-(2,3-디하이드록시프로폭시)-치오크로만을 10ml의 디메틸포름아미드에 용해시키고, 0.24g의 나트륨수산화물을 가한다. 80℃로 30분간 가열해준 다음, 디메틸포름아미드에 4.95g의 N-메틸-N-페닐아미노트리페닐포스포늄 요오드가 용해된 용액과 디메틸포름아미드에 1.46g의 3차 부틸아민을 넣은 용액을 가해준다. 반응혼합물을 80℃로 약 2시간동안 가열한 다음 실온으로 냉각시킨다. 용매를 감압하에서 증류시킨 다음 잔류물을 클로로포름에 용해시킨다. 유기용액을 N/10염산용액으로 추출한다. 산부분은 모아서 나트륨 수산화물로 염기성이 되게 해 주고 에테르로 3회 추출한다. 에테르용액은 물로 세척하고, 황산 마그네슘 위에서 건조시킨 후, 여과하여 증발시킨다. 유상잔사의 무게는 2.4g이다. 이를 실리카위에서 크로마토그라피 시키고 벤젠-메탄올(1 : 1)로 용출시켜 정제시킨다. 용매의 증류에 의하여 60%의 수율로 원하는 dl 8-(3-3차 부틸아미노-2-하이드록시프로폭시)-치오크로만을 얻는다.Only 2.4 g of 8- (2,3-dihydroxypropoxy) -thiochrome is dissolved in 10 ml of dimethylformamide and 0.24 g of sodium hydroxide are added. After heating at 80 ° C. for 30 minutes, a solution containing 4.95 g of N-methyl-N-phenylaminotriphenylphosphonium iodine dissolved in dimethylformamide and 1.46 g of tertiary butylamine in dimethylformamide were added thereto. give. The reaction mixture is heated to 80 ° C. for about 2 hours and then cooled to room temperature. The solvent is distilled off under reduced pressure and then the residue is dissolved in chloroform. The organic solution is extracted with N / 10 hydrochloric acid solution. The acid portion is collected and made basic with sodium hydroxide and extracted three times with ether. The ether solution is washed with water, dried over magnesium sulfate, filtered and evaporated. The oily residue weighs 2.4g. It was purified by chromatography on silica and eluted with benzene-methanol (1: 1). Distillation of the solvent gives only the desired dl 8- (tert-butylamino-2-hydroxypropoxy) -chiroch in 60% yield.
이는 70-72℃에서 용해된다.It dissolves at 70-72 ° C.
[실시예 2]Example 2
[덱스트로로타토리 8-(3-2차 부틸아미노-2하이드록시프로폭시)-치오크로만][Dextrorotatori 8- (3-tert-Butylamino-2hydroxypropoxy) -thiochromo]
실시예(Ⅰ)의 공정을 사용하고, 실시예(Ⅰ)의 단계(A)에서 얻어진 8-(2,3-디하이드록시프로폭시)-치오크로만과(+) 2차부틸아민을 출발물질로 하여 수율 55%로 덱스트로로타토리 8-(3-2차 부틸 아미노-2-하이드록시프로폭시)-치오크로만을 얻는다. 이는 80-88℃에서 용해된다.Using the process of Example (I), starting 8- (2,3-dihydroxypropoxy) -thiochroman and (+) secondary butylamine obtained in step (A) of Example (I) As a material, only the dextrose rotator 8- (3-tert-butyl amino-2-hydroxypropoxy) -thioke was obtained in a yield of 55%. It dissolves at 80-88 ° C.
[실시예 3]Example 3
[레보로타토리 8-(3-2차 부틸아미노-2-하이드록시프로폭시)-치오크로만][Reborotatori 8- (3-tert-Butylamino-2-hydroxypropoxy) -thiochromo]
실시예(Ⅱ)에 기술된 방식에 의해 (-) 2급 부틸아민으로부터 출발하여 수율 55%로 레보로타토리 8-(3-2급 부틸아미노-2-하이드록시프로폭시)-치오크로만이 얻어진다.Levorottori 8- (3-tert-Butylamino-2-hydroxypropoxy) -thiochrome only with a yield of 55% starting from (-) secondary butylamine by the manner described in Example (II) Obtained.
[출발물질의 제조][Production of Starting Material]
300g의 폴리인산을 수조에서 40℃가 될 때까지 천천히 가열해 주고, 이 온도에 도달될 때, 30g의 (오르조 메톡시페닐) 치오프로 피온산을 90분 이내에 가해준다. 모든 점성의 혼합물을 2시간동안 교반하여 방치한 다음 파쇄된 얼음위에 유출시킨다. 과잉의 반응제를 가수분해한 다음 생성된 치오크로만 유도체를 여과에 의하여 분리하고, 건조시켜서 물로 세척한 다음 오븐에서 더 건조시킨다. 이렇게하면 21.9g의 8-메톡시 치오크로만 4-온 이 황색의 분말로서 얻어지는데 이것은 대기중의 산소에 의하여 쉽게 산화된다. 순수한 화합물은 98-110℃에서 용해된다 (수율= 80%). 23.96g의 8-메톡시 치오크로만 4-one을 하이드라진 수화물 27.4ml와 에틸렌글리콜 112ml의 혼합물과 함께 플라스크에 채워넣는다. 이 혼합물을 실온이 될 때까지 가열해 준다.300 g of polyphosphoric acid is slowly heated in a water bath until it reaches 40 ° C. and when this temperature is reached, 30 g of (orzo methoxyphenyl) chioff is added within 90 minutes. All viscous mixture is left to stir for 2 hours and then spilled on crushed ice. The excess reactant is hydrolyzed and the resulting cheochromemann derivative is isolated by filtration, dried, washed with water and further dried in an oven. This yields 21.9 g of 8-methoxy thiochroman 4-one as a yellow powder, which is easily oxidized by oxygen in the atmosphere. Pure compound is dissolved at 98-110 ° C. (yield = 80%). 23.96 g of 8-methoxy thiochroman 4-one is charged into a flask with a mixture of 27.4 ml of hydrazine hydrate and 112 ml of ethylene glycol. Heat this mixture to room temperature.
다음에 가성칼륨 15.8g을 격렬히 교반하면서 가해준다. 알칼리성 시약이 용해되면 생성된 물을 증류에 의해 제거하는 동안 혼합물을 환류 가열시킨다. 온도를 205-210℃까지 점진적으로 증가시킨 다음 2온도에서 6시간동안 다시 가열해준 다음 반응 혼합물을 실온으로 되돌아가게 하고, 하이드라진 수화물 10㎖를 더해서 6시간동안 다시 가열해준 다음 반응 혼합물을 냉수에 유출시킨다. 이현탁액에 염산을 가함으로서 산성으로 하고, 수성 현탁액은 클로로포름으로 3회 추출한다. 클로로포름 용액층을 한데모아 물로 세척한 다음 건조시켜 증발시킨다. 건조 잔류물을 분류에 의하여 정제된다.Next, 15.8 g of caustic potassium is added with vigorous stirring. Once the alkaline reagent is dissolved, the mixture is heated to reflux while the resulting water is removed by distillation. The temperature was gradually increased to 205-210 ° C. and then heated again at 2 ° C. for 6 hours, then the reaction mixture was returned to room temperature, 10 ml of hydrazine hydrate was added and heated again for 6 hours, then the reaction mixture was poured into cold water. Let's do it. The suspension is acidified by adding hydrochloric acid, and the aqueous suspension is extracted three times with chloroform. The chloroform solution layer is combined, washed with water, dried and evaporated. Dry residue is purified by fractionation.
순수한 화합물은 104-106°/0.1mmHg에서 주 분류로부터 회수된다. 수득양은 약 13.61g 즉, 수율은 67%이다.Pure compounds are recovered from the main fraction at 104-106 ° / 0.1 mmHg. The yield is about 13.61 g, that is, the yield is 67%.
8-하이드록시 치오크로만은 86-88℃에서 용해되는 무색의 화합물이다. 증류액인 물-글리콜로부터 치오크로만이 더 회수되기도 한다.8-hydroxy thiochroman is a colorless compound that dissolves at 86-88 ° C. Only the chelates are further recovered from the distillate water-glycol.
증류액은 클로로포름으로 추출된다. 클로로포름 용액을 희염산과 물로 세척한 다음 건조시켜 증발시키면 8-메톡시 치오크로만 3.11g이 점성 액체로서 회수된다.The distillate is extracted with chloroform. The chloroform solution is washed with dilute hydrochloric acid and water, then dried and evaporated to recover 3.11 g of 8-methoxy thiol as a viscous liquid.
비등점 = 115-118°/0.06mmHg.Boiling point = 115-118 ° / 0.06 mmHg.
+1,16110 +1,16110
8-메톡시 치오크로만은 염화메틸렌내에서 복합 보론트리플루오라이드-아세트산에 의하여 탈메틸화시킴으로서 8-히드록시치오크로만으로 전환된다.8-methoxy thiochromen is converted to 8-hydroxythiochrome by demethylation by complex borontrifluoride-acetic acid in methylene chloride.
이로써 두 번째의 8-하이드록시치오크로만이 얻어진다.This gives only a second 8-hydroxythioke.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR7701932A KR810000557B1 (en) | 1977-08-19 | 1977-08-19 | Manufacturing Process of Chiochroman Derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR7701932A KR810000557B1 (en) | 1977-08-19 | 1977-08-19 | Manufacturing Process of Chiochroman Derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR810000557B1 true KR810000557B1 (en) | 1981-06-01 |
Family
ID=19204782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR7701932A Expired KR810000557B1 (en) | 1977-08-19 | 1977-08-19 | Manufacturing Process of Chiochroman Derivatives |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR810000557B1 (en) |
-
1977
- 1977-08-19 KR KR7701932A patent/KR810000557B1/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU193161B (en) | Process for preparing new n-alkyl-norscopines | |
| US3105854A (en) | Meta-substituted phenoxyethylamines | |
| KR810000557B1 (en) | Manufacturing Process of Chiochroman Derivatives | |
| US3960856A (en) | Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide | |
| DK173252B1 (en) | Alkoxymethyl ethers of glycerols | |
| SU880251A3 (en) | Method of preparing thiochromane derivatives or their salts | |
| AU2767292A (en) | Cyclic peroxyacetal compounds | |
| US20030120068A1 (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
| CA1262139A (en) | Process for the preparation of 2,3- dihydrobenzopyranone derivatives | |
| US1747531A (en) | Werner schulemann | |
| US4125711A (en) | Process for preparing auranofin | |
| US2653949A (en) | 1-(di-n-butylaminoalkylamino)-4-methylthiaxanthones and synthesis thereof | |
| US4169839A (en) | Method of preparing a 3-iodothiophene | |
| US4057585A (en) | Method of preparing 2,3-dichloroanisole | |
| KR880000154B1 (en) | Method of preparing aminonitropyridine | |
| DE3405332A1 (en) | Novel allylamines, process for their preparation, and their use | |
| KR810001319B1 (en) | Process for the preparation of new isobutyramide derivatives | |
| KR910009415B1 (en) | Process for the preparation of bis-(phemoxy) acethyl-dimethyl amide | |
| US4585867A (en) | Process for the preparation of 4-quinolinones | |
| WO1990006915A1 (en) | Process for producing 2-alkyl- and 2-(substituted alkyl)-4-alkylthio and alkylsulfonyl-benzoic acids and their derivatives | |
| US4113738A (en) | Conversion of N-tosylsulfoximides to sulfoximines | |
| KR870001920B1 (en) | Process for preparation of 7-cl-1,2,2,4-tetrahydroquinoline-4-one | |
| KR850000427B1 (en) | Method for preparing pyrrole derivative | |
| KR0174333B1 (en) | Process for preparing fluoran dye | |
| US20040176591A1 (en) | Novel synthesis and crystallization of peperazine ring-containing compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19770819 |
|
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19810411 Patent event code: PE09021S01D |
|
| PG1605 | Publication of application before grant of patent |
Comment text: Decision on Publication of Application Patent event code: PG16051S01I Patent event date: 19810430 |
|
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19810811 |
|
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 19810821 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 19810821 End annual number: 3 Start annual number: 1 |
|
| PR1001 | Payment of annual fee |
Payment date: 19830418 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 19840420 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 19850503 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 19860421 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 19870421 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 19880425 Start annual number: 9 End annual number: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 19890504 Start annual number: 10 End annual number: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 19900907 Start annual number: 11 End annual number: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 19910426 Start annual number: 12 End annual number: 12 |
|
| PC1801 | Expiration of term |